Davis J W, Nininger R J, Phillips P E
Am J Clin Nutr. 1975 Aug;28(8):930-3. doi: 10.1093/ajcn/28.8.930.
Methylhistidines are among the amino acids which are present in increased concentrations in the plasma of severely uremic patients who may have a hemorrhagic diathesis. Histidine contains an imidazole ring, and our previous work has shown inhibition of collagen-induced platelet aggregation by imidazole in concentrations as low as 0.5 mM. Collagen-induced, adenosine diphosphate-induced, and norepinephrine-induced platelet aggregation were tested in platelet-rich plasma by a turbidimetric technique after incubation of the plasma with varying concentrations of the methylhistidines for 1 hour. Platelet aggregation was unaffected by methylhistidine concentrations up to 0.6 mM. Only norepinephrine-induced platelet aggregation was slightly inhibited at a concentration of 4.7 (mM far higher than found in uremic patients). The imidazole ring as a portion of the methylhistidine molecule appears to have lost much of its effect on platelet aggregation.
甲基组氨酸是严重尿毒症患者血浆中浓度升高的氨基酸之一,这些患者可能有出血倾向。组氨酸含有一个咪唑环,我们之前的研究表明,咪唑在低至0.5 mM的浓度下就能抑制胶原蛋白诱导的血小板聚集。在富含血小板的血浆中,将血浆与不同浓度的甲基组氨酸孵育1小时后,通过比浊法检测胶原蛋白诱导、二磷酸腺苷诱导和去甲肾上腺素诱导的血小板聚集。甲基组氨酸浓度高达0.6 mM时,血小板聚集不受影响。只有在浓度为4.7 mM(远高于尿毒症患者体内的浓度)时,去甲肾上腺素诱导的血小板聚集才略有抑制。甲基组氨酸分子中的咪唑环似乎已失去了对血小板聚集的大部分作用。